MarilynTelenMD

Blood Banking & Transfusion Medicine, Sickle Cell & Other Anemias

Professor, Medicine, Duke University School of Medicine

Dr. Telen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis Start of enrollment: 2010 May 01
Completed
Phase 2
Effect of Broccoli Sprouts Homogenate on SS RBC Start of enrollment: 2012 Mar 01
Completed
Not Applicable
A Phase II Trial of Regadenoson in Sickle Cell Anemia Start of enrollment: 2013 Jul 01
Completed
Phase 2
Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE) Start of enrollment: 2020 Feb 26
Recruiting
Phase 3
Roles: Contact, Principal Investigator
Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers Start of enrollment: 2018 Apr 06
Completed
Phase 2
Roles: Contact
Join now to see all

PubMed

142 citations
Genetic diversity fuels gene discovery for tobacco and alcohol use.
Gretchen R B Saunders, Xingyan Wang, Fang Chen, Seon-Kyeong Jang, Mengzhen Liu
Nature. 2022-12-01
15 citations
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
Carlton D Dampier, Marilyn Jo Telen, Ted Wun, R Clark Brown, Payal Desai
Blood. 2023-01-12
116 citations
Therapeutic strategies for sickle cell disease: towards a multi-agent approach.
Marilyn J. Telen, Punam Malik, Gregory M. Vercellotti
Nature Reviews. Drug Discovery. 2019-02-01

Abstracts/Posters

Identification of Optimal Thalassemia Screening Strategies for Migrant Populations in Thailand: A Mixed-Methods Approach
Marilyn J. Telen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Phase 1 Single (SAD) and Multiple Ascending Dose (MAD) Studies of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of FT-4202, an Allosteric A...
Marilyn J. Telen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Knowledge, Cultural, and Structural Barriers to Thalassemia Screening in Migrant Populations in Thailand
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Forma Therapeutics Announces Presentations at Upcoming Hematology ConferencesJune 10th, 2022
Biomedicine: Speeding up Sickle Cell TreatmentMarch 17th, 2017